Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.630
-0.070 (-4.12%)
At close: Apr 1, 2025, 4:00 PM
1.675
+0.045 (2.73%)
After-hours: Apr 1, 2025, 4:25 PM EDT
Entera Bio Employees
As of December 31, 2023, Entera Bio had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees increased by 1 or 5.88% compared to the previous year.
Employees
18
Change (1Y)
1
Growth (1Y)
5.88%
Revenue / Employee
$10,056
Profits / Employee
-$530,056
Market Cap
60.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENTX News
- 4 days ago - Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 15 days ago - OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders - GlobeNewsWire
- 5 weeks ago - Entera Bio to Participate in Upcoming Events - GlobeNewsWire
- 2 months ago - Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 5 months ago - Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 months ago - Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders - GlobeNewsWire
- 8 months ago - Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewsWire
- 8 months ago - Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewsWire